You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
力生製藥(002393.SZ):擬掛牌轉讓生化製藥天津空港經濟區環河南路9號房地產及部分設備
格隆匯 06-30 21:06

格隆匯6月30日丨力生製藥(002393.SZ)公佈,此前披露,公司於2020年12月28日召開的第六屆董事會第二十二次會議、2021年02月05日召開的2021年第一次臨時股東大會通過決議,終止天津生物化學制藥有限公司(“生化製藥”)23價肺炎球菌多糖疫苗項目(“該項目”),該項目坐落地為天津空港經濟區環河南路9號。

該項目終止後所屬土地,房產,設備等資產(“該項目資產”或“擬轉讓資產”)利用效率較低,為盤活資產,提高運營效率,降低運營成本,優化公司資產結構,公司擬將該項目資產在天津產權交易中心公開掛牌轉讓。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account